This month’s (March) patient meeting included a presentation by Endocrinology Specialist Nurses from Manchester Royal Infirmary. This was a talk we requested as we know secondary adrenal insufficiency is a concern for many patients.
Allergic bronchopulmonary aspergillosis (ABPA) is a complex respiratory condition that occurs when the immune system overreacts to the Aspergillus fungus, leading to inflammation and potential lung damage. To manage the symptoms of ABPA, patients are often prescribed corticosteroid medications. However, long-term use of these medications can lead to a condition called secondary adrenal insufficiency. Watch the talk below to learn more about the condition, it’s diagnosis, management and treatment.
Share this post
Latest News posts
Aspergillus in a well-loved pillow written by Caroline Hawkridge
January 23, 2019
Patients meeting November 2018
January 11, 2019
Patients meeting August 2018
January 11, 2019
Patients meeting July 2018
January 11, 2019
Patients meeting May 2018
January 11, 2019
Patients meeting April 2018
January 11, 2019
Patients meeting March 2018
January 11, 2019
Patients meeting 8th AAA, Lisbon February 2018
January 11, 2019
Patients & Carers meeting December 2017
January 11, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video